These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7752647)

  • 1. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
    Schulz R; Rose J; Skyschally A; Heusch G
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine.
    Indolfi C; Guth BD; Miura T; Miyazaki S; Schulz R; Ross J
    Circulation; 1989 Oct; 80(4):983-93. PubMed ID: 2791256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent.
    O'Brien P; Drage D; Saeian K; Brooks HL; Warltier DC
    Am Heart J; 1992 Mar; 123(3):566-74. PubMed ID: 1539507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia.
    Guth BD; Heusch G; Seitelberger R; Matsuzaki M; Ross J
    Eur Heart J; 1987 Dec; 8 Suppl L():61-8. PubMed ID: 3451884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
    Dämmgen JW; Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of benefit in the ischemic myocardium due to heart rate reduction.
    Guth BD; Indolfi C; Heusch G; Seitelberger R; Ross J
    Basic Res Cardiol; 1990; 85 Suppl 1():157-66. PubMed ID: 1965395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis.
    Guth BD; Heusch G; Seitelberger R; Ross J
    Circulation; 1987 Mar; 75(3):661-9. PubMed ID: 3815774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a bradycardic agent on the isolated blood-perfused canine heart.
    Schipke JD; Harasawa Y; Sugiura S; Alexander J; Burkhoff D
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):481-8. PubMed ID: 1854656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery thrombosis and thrombolysis in baboons: the effect of atenolol treatment on myocardial infarct size.
    Herijgers P; Flameng W
    Eur Heart J; 1991 Oct; 12(10):1084-8. PubMed ID: 1782934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.
    Matsuzaki M; Guth B; Tajimi T; Kemper WS; Ross J
    Circulation; 1985 Jul; 72(1):233-43. PubMed ID: 4006133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
    Gout B; Jean J; Bril A
    J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs.
    Raberger G; Krumpl G; Schneider W
    Int J Cardiol; 1987 Mar; 14(3):343-54. PubMed ID: 3557712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):59-65. PubMed ID: 1576097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
    Krumpl G; Winkler M; Schneider W; Raberger G
    Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels.
    Schulz R; Rose J; Post H; Heusch G
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2294-301. PubMed ID: 7611480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats.
    Tanaka H; Obata H; Haneda T
    Jpn Circ J; 1991 Dec; 55(12):1233-45. PubMed ID: 1837320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation.
    Schulz R; Guth BD; Pieper K; Martin C; Heusch G
    Circ Res; 1992 Jun; 70(6):1282-95. PubMed ID: 1576742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high arterial oxygen tension on function, blood flow distribution, and metabolism in ischemic myocardium.
    Cason BA; Wisneski JA; Neese RA; Stanley WC; Hickey RF; Shnier CB; Gertz EW
    Circulation; 1992 Feb; 85(2):828-38. PubMed ID: 1735173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of coronary perfusion on regional myocardial function within the autoregulatory range in pigs. Evidence against the Gregg phenomenon.
    Schulz R; Guth BD; Heusch G
    Circulation; 1991 Apr; 83(4):1390-403. PubMed ID: 2013156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.